Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1992 3
1993 3
1994 2
1996 2
1997 5
1998 2
1999 3
2000 12
2001 1
2002 7
2003 3
2004 7
2005 1
2006 4
2007 9
2008 11
2009 8
2010 8
2011 6
2012 7
2013 14
2014 9
2015 8
2016 7
2017 5
2018 5
2019 8
2020 8
2021 7
2022 8
2023 4
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotics for asymptomatic bacteriuria in pregnancy.
Smaill FM, Vazquez JC. Smaill FM, et al. Cochrane Database Syst Rev. 2019 Nov 25;2019(11):CD000490. doi: 10.1002/14651858.CD000490.pub4. Cochrane Database Syst Rev. 2019. PMID: 31765489 Free PMC article.
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Afkhami S, D'Agostino MR, Zhang A, Stacey HD, Marzok A, Kang A, Singh R, Bavananthasivam J, Ye G, Luo X, Wang F, Ang JC, Zganiacz A, Sankar U, Kazhdan N, Koenig JFE, Phelps A, Gameiro SF, Tang S, Jordana M, Wan Y, Mossman KL, Jeyanathan M, Gillgrass A, Medina MFC, Smaill F, Lichty BD, Miller MS, Xing Z. Afkhami S, et al. Among authors: smaill f. Cell. 2022 Mar 3;185(5):896-915.e19. doi: 10.1016/j.cell.2022.02.005. Epub 2022 Feb 9. Cell. 2022. PMID: 35180381 Free PMC article.
Immunological considerations for COVID-19 vaccine strategies.
Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Jeyanathan M, et al. Among authors: smaill f. Nat Rev Immunol. 2020 Oct;20(10):615-632. doi: 10.1038/s41577-020-00434-6. Epub 2020 Sep 4. Nat Rev Immunol. 2020. PMID: 32887954 Free PMC article. Review.
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
Orkin C, Molina JM, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Jin Xu Z, Asante-Appiah E, Sklar P, Teppler H, Lahoulou R; DRIVE-FORWARD and DRIVE-AHEAD collaborators. Orkin C, et al. Lancet HIV. 2024 Feb;11(2):e75-e85. doi: 10.1016/S2352-3018(23)00258-8. Epub 2023 Dec 20. Lancet HIV. 2024. PMID: 38141637 Clinical Trial.
174 results